Progyny, Inc. Announces Details for Its First Quarter 2021 Results Report
Progyny, Inc. (Nasdaq: PGNY) will report its financial results for Q1 2021 on May 6, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Progyny, Inc. (Nasdaq: PGNY) will report its financial results for Q1 2021 on May 6, 2021, after market close. The company specializes in fertility and family building benefits. A conference call will follow at 4:45 PM ET, with access details for both U.S. and international participants provided. An audio replay will be available until May 14, 2021. Progyny is recognized for its innovative approach in the fertility sector, supporting patients and employers alike. Further information can be found on their website.
Positive
- Progyny is recognized for its innovative fertility benefits management approach, enhancing patient care.
- The company has received accolades from notable organizations, indicating strong performance and growth potential.
Negative
- None.
Details
News Market Reaction – PGNY
The recorded move for PGNY in the trading session of this news was +1.25%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2021 after the close of the market on Thursday, May 6, 2021.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Friday, May 14, 2021 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.